Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Rob Walton, CEO, SPT Labtech
    14 January 2026

    SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT’s firefly platform

    Automated Twist NGS library preparation workflows available on SPT Labtech’s firefly platform via the firefly cloud Validated methods support Twist FlexPrep™ UHT and Enzymatic Fragmentation Kit 2.0, enabling higher throughput and reproducibility in NGS library preparationCambridge, UK, ...

    https://axolbio.com/
    13 January 2026

    Axol Bioscience raises $2.8M to advance US expansion and product development

    Financing led by US life sciences investor, BroadOak Capital Partners Investment to support expansion of US operations, product development, and cell manufacturing scale-upCambridge / Edinburgh, UK, 13th January 2026: Axol Bioscience Ltd. (Axol), a leading provider of induced pluripoten...

    Will Edwards, CEO, Astoriom
    14 January 2026

    Astoriom appoints Will Edwards as Chief Executive Officer

    Strategic appointment to support global scale-up of sample management operations

    A group of people sitting around a large table in an office, with a trainer standing at the end of the table in front of a large wall-mounted screen
    13 January 2026

    Free CPD event on fume cupboard safety and sustainability at Cambridge Science Park

    On February 4th, Clean Air is hosting a free, accredited CPD session at Cambridge Science Park focused on how fume cupboards can be operated more safely and sustainably in commercial laboratories. The session will help attendees better understand the factors that influence containment p...

    Accelerate@Babraham banner
    13 January 2026

    Accelerate@Babraham applications now open

    Starting something new is hard – particularly within the fast-moving life science sector.  ...

    Dr Nathan Brown, Director of Science at Optibrium
    13 January 2026

    Optibrium appoints Dr Nathan Brown as Director of Science

    Newly created role underscores commitment to customer-driven research and scientific excellenceCAMBRIDGE, UK, 13 January 2026 – Optibrium, a leading developer of software and AI solutions for molecular design, today announced the appointment of Dr Nathan Brown as Director...

    Michael Chen, CEO and co-founder, Nuclera
    13 January 2026

    Nuclera extends Series C funding to $87M to advance antibody engineering

    Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK GohThe funding will accelerate development of eProtein Discovery for full-format antibody expression, purification, and binding validationCambridg...

    man and women looking at a screen
    12 January 2026

    Why cultural literacy has become an execution skill in life sciences

    In life sciences, execution failures are often explained in familiar terms: regulatory complexity, funding constraints, or technological readiness. Yet in practice, many promising initiatives stall or unravel for a quieter reason — misaligned assumptions between people, professions and ...

    OutSee’s leadership team – James Peach (Left), COO, Dr Julian Gough (Centre), CEO and Founder, and Dr Chang Lu (Right), CSO
    12 January 2026

    OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate

    Oversubscribed £2.5M seed round led by Ahren Innovation CapitalStrategic collaboration with o2h to progress drug discovery programmeCambridge, UK, 12 January 2026: OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery...

    Steve Smith, CEO, iXCells Biotechnologies
    12 January 2026

    iXCells Biotechnologies appoints Steve Smith as CEO

    Appointment strengthens leadership team as iXCells focuses on expanding its portfolio of custom-tailored iPSC products and delivery of enhanced preclinical services ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 44
    • Page 45
    • Current page 46
    • Page 47
    • Page 48
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS